-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Systemic Barriers to Curative Therapy and Need for Integrated Care

Program: Spotlight Sessions
Session: Curative Therapies for Sickle Cell Disease: Option for Some but Not Quite All
Hematology Disease Topics & Pathways:
Clinical Practice (Health Services and Quality)
Sunday, December 8, 2024, 4:30 PM-5:45 PM

Payal Desai, MD

Wake Forest University, Charlotte, NC; Levine Cancer Institute, Department of Hematology, Atrium Health, Charlotte, NC

Disclosures: Desai: National Marrow Donor Program: Other: Medical Monitor; Bluebird Bio: Honoraria; Chiesi: Honoraria; Novartis: Research Funding; Novo Nordisk: Research Funding.

See more of: Curative Therapies for Sickle Cell Disease: Option for Some but Not Quite All
See more of: Spotlight Sessions
<< Previous Presentation | Next Presentation